Stay updated on Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page.

Latest updates to the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page
- ChecktodayChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check8 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedRevision: v3.4.2 is now displayed; the government funding operating-status notice (and the v3.4.1 revision note) has been removed.SummaryDifference0.3%

- Check43 days agoChange DetectedA new site-wide notice about potential delays due to a lapse in government funding has been added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check50 days agoChange DetectedThese are minor UI/metadata updates that do not modify core study content. They include showing the glossary option, updated capitalization for 'Last Update Submitted that Met QC Criteria', the replacement of 'No FEAR Act data' with 'No FEAR Act Data', and the revision number updated to v3.4.0.SummaryDifference0.1%

- Check86 days agoChange DetectedIntroduced a consolidated Locations section listing all study sites by state (Arizona, California, Colorado, Florida, Georgia, Illinois, Massachusetts, Michigan, Minnesota, New Jersey, Ohio, Pennsylvania, Tennessee, Texas, Utah, Washington). The previous per-state location entries were removed.SummaryDifference1%

Stay in the know with updates to Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page.